Skip to main content
. 2012 Dec;19(6):e428–e435. doi: 10.3747/co.19.1152

TABLE V.

Factors associated with abstract quality scores

Parameter Estimatea p Value Median quality scoreb
Meeting
  ispor Ref 0.3100 75.0
  asco 1.61 82.1
  ash −2.27 75.0
Year
  1997–2000 Ref 0.0014 67.9
  2001–2003 3.32 73.2
  2004–2006 6.58 76.8
  2007–2009 8.38 78.6
Site
  Other Ref 0.1034 72.3
  Europe −0.15 76.8
  North America 0.39 75.0
Cancer
  Other Ref 0.0053 73.2
  Breast 2.28 75.9
  Gastrointestinal 3.10 75.0
  Genitourinary 4.71 78.6
  Gynecologic 0.82 64.3
  Hematologic 7.45 82.1
  Lung −5.45 69.6
Type
  Other Ref 0.7315 79.5
  cea −2.19 73.2
  cma −3.24 75.0
  cua −0.93 76.8
a

Beta estimates are presented in this linear regression model.

b

Abstract scores have been normalized.

ispor = International Society for Pharmacoeconomics and Outcomes Research; Ref = reference variable; asco = American Society of Clinical Oncology; ash = American Society of Hematology; cea = cost-effectiveness analysis; cma = cost-minimization analysis; cua = cost–utility analysis.